INTRODUCTION
Voveran AQ Injection is a pain-relieving medicine. It is used to treat pain, swelling, stiffness, and joint pain in conditions like rheumatoid arthritis, osteoarthritis, and acute musculoskeletal injuries. It is given in cases where oral administration is not possible.
Voveran AQ Injection is administered as an injection by a healthcare professional. Kindly do not self administer. Inform your doctor if you have any history of heart disease or stroke. Please consult your doctor in case any injection site reactions like pain, swelling, or redness are observed.
The most common side effects of this medicine include nausea, limb discomfort, and injection site reactions. Your doctor may regularly monitor your kidney function, liver function, and levels of blood components if you are taking this medicine for long-term treatment. Long term use may lead to serious complications such as stomach bleeding and kidney problems.
USES OF VOVERAN INJECTION
PAIN RELIEF
BENEFITS OF VOVERAN INJECTION
In Pain relief
Voveran AQ Injection belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling. It works by blocking chemical messengers in the brain that tell us we have pain. It is given as an injection by your healthcare provider and should not be self-administered.
SIDE EFFECTS OF VOVERAN INJECTION
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Voveran
- Nausea
- Limb pain
- Injection site reactions (pain, swelling, redness)
HOW TO USE VOVERAN INJECTION
Your doctor or nurse will give you this medicine. Kindly do not self administer.
HOW VOVERAN INJECTION WORKS
Voveran AQ Injection is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
Reviews
There are no reviews yet.